HK1178884A1 - - Google Patents
Info
- Publication number
- HK1178884A1 HK1178884A1 HK13105590.8A HK13105590A HK1178884A1 HK 1178884 A1 HK1178884 A1 HK 1178884A1 HK 13105590 A HK13105590 A HK 13105590A HK 1178884 A1 HK1178884 A1 HK 1178884A1
- Authority
- HK
- Hong Kong
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10305035 | 2010-01-13 | ||
| PCT/EP2011/050295 WO2011086075A1 (de) | 2010-01-13 | 2011-01-12 | 2,5,7-substituierte oxazolopyrimidinderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1178884A1 true HK1178884A1 (xx) | 2013-09-19 |
Family
ID=41820512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13105590.8A HK1178884A1 (xx) | 2010-01-13 | 2013-05-10 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8785439B2 (xx) |
| EP (1) | EP2523961B1 (xx) |
| JP (1) | JP5844276B2 (xx) |
| KR (1) | KR101759126B1 (xx) |
| CN (1) | CN102791716B (xx) |
| AR (1) | AR079980A1 (xx) |
| AU (1) | AU2011206611B2 (xx) |
| BR (1) | BR112012017393A2 (xx) |
| CA (1) | CA2791445C (xx) |
| DK (1) | DK2523961T3 (xx) |
| ES (1) | ES2448645T3 (xx) |
| HK (1) | HK1178884A1 (xx) |
| IL (1) | IL220707A (xx) |
| MX (1) | MX2012007835A (xx) |
| MY (1) | MY156525A (xx) |
| PT (1) | PT2523961E (xx) |
| RU (1) | RU2557246C2 (xx) |
| SG (1) | SG183101A1 (xx) |
| TW (1) | TWI485153B (xx) |
| UY (1) | UY33176A (xx) |
| WO (1) | WO2011086075A1 (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011206617B2 (en) | 2010-01-14 | 2015-07-16 | Sanofi | 2,5-substituted oxazolopyrimidine derivatives |
| US8846690B2 (en) * | 2010-01-14 | 2014-09-30 | Sanofi | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| AR079997A1 (es) * | 2010-01-14 | 2012-03-07 | Sanofi Aventis | Derivados de acido carboxilico de oxazolo[5,4-d]pirimidinas utiles en el tratamiento del sindrome del pie diabetico(dfs), composiciones farmaceuticas que los contienen y metodo de preparacion de los mismos. |
| US9321787B2 (en) | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
| MX2018000202A (es) | 2015-07-02 | 2018-06-27 | Horizon Orphan Llc | Analogos de cisteamina resistentes a la ado y sus usos. |
| TWI794742B (zh) | 2020-02-18 | 2023-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| US11697666B2 (en) | 2021-04-16 | 2023-07-11 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004234110A1 (en) | 2003-04-25 | 2004-11-11 | Rega Foundation | Heterocyclic compounds for use in the treatment of viral infections |
| PE20050158A1 (es) * | 2003-05-19 | 2005-05-12 | Irm Llc | Compuestos inmunosupresores y composiciones |
| FR2865208B1 (fr) * | 2004-01-16 | 2009-01-16 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.1]octanecarboxmique, leur preparation et leur application en therapeutique |
| WO2007061458A2 (en) * | 2005-11-23 | 2007-05-31 | Epix Delaware, Inc. | S1p receptor modulating compounds and use thereof |
| EP1900729A1 (en) * | 2006-09-15 | 2008-03-19 | Novartis AG | Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors |
| EP2121648A2 (en) | 2007-03-21 | 2009-11-25 | EPIX Pharmaceuticals, Inc. | S1p receptor modulating compounds and use thereof |
| TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
| NZ590377A (en) | 2008-07-15 | 2011-11-25 | Sanofi Aventis | Oxazolopyrimidines as edg-1 receptor agonists |
| UY33177A (es) | 2010-01-13 | 2011-08-31 | Sanofi Aventis | Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido |
| AR079982A1 (es) | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5,7- sustituido., composiciones farmaceuticas y procesos para prepararlos. |
| US8846690B2 (en) | 2010-01-14 | 2014-09-30 | Sanofi | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| AU2011206617B2 (en) | 2010-01-14 | 2015-07-16 | Sanofi | 2,5-substituted oxazolopyrimidine derivatives |
| AR079997A1 (es) | 2010-01-14 | 2012-03-07 | Sanofi Aventis | Derivados de acido carboxilico de oxazolo[5,4-d]pirimidinas utiles en el tratamiento del sindrome del pie diabetico(dfs), composiciones farmaceuticas que los contienen y metodo de preparacion de los mismos. |
-
2011
- 2011-01-11 TW TW100100889A patent/TWI485153B/zh not_active IP Right Cessation
- 2011-01-11 AR ARP110100073A patent/AR079980A1/es unknown
- 2011-01-11 UY UY0001033176A patent/UY33176A/es not_active Application Discontinuation
- 2011-01-12 CN CN201180013739.0A patent/CN102791716B/zh not_active Expired - Fee Related
- 2011-01-12 EP EP11700403.6A patent/EP2523961B1/de active Active
- 2011-01-12 MY MYPI2012002587A patent/MY156525A/en unknown
- 2011-01-12 BR BR112012017393A patent/BR112012017393A2/pt not_active IP Right Cessation
- 2011-01-12 ES ES11700403.6T patent/ES2448645T3/es active Active
- 2011-01-12 PT PT117004036T patent/PT2523961E/pt unknown
- 2011-01-12 CA CA2791445A patent/CA2791445C/en not_active Expired - Fee Related
- 2011-01-12 SG SG2012051124A patent/SG183101A1/en unknown
- 2011-01-12 KR KR1020127021144A patent/KR101759126B1/ko active IP Right Grant
- 2011-01-12 RU RU2012134349/04A patent/RU2557246C2/ru not_active IP Right Cessation
- 2011-01-12 US US13/521,823 patent/US8785439B2/en active Active
- 2011-01-12 AU AU2011206611A patent/AU2011206611B2/en not_active Ceased
- 2011-01-12 DK DK11700403.6T patent/DK2523961T3/en active
- 2011-01-12 MX MX2012007835A patent/MX2012007835A/es active IP Right Grant
- 2011-01-12 JP JP2012548406A patent/JP5844276B2/ja not_active Expired - Fee Related
- 2011-01-12 WO PCT/EP2011/050295 patent/WO2011086075A1/de active Application Filing
-
2012
- 2012-07-01 IL IL220707A patent/IL220707A/en not_active IP Right Cessation
-
2013
- 2013-05-10 HK HK13105590.8A patent/HK1178884A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW201141873A (en) | 2011-12-01 |
| RU2012134349A (ru) | 2014-02-20 |
| CA2791445C (en) | 2017-08-29 |
| CN102791716A (zh) | 2012-11-21 |
| ES2448645T3 (es) | 2014-03-14 |
| JP2013517238A (ja) | 2013-05-16 |
| PT2523961E (pt) | 2014-03-20 |
| KR20120115544A (ko) | 2012-10-18 |
| US20130137685A1 (en) | 2013-05-30 |
| MY156525A (en) | 2016-02-26 |
| SG183101A1 (en) | 2012-09-27 |
| US8785439B2 (en) | 2014-07-22 |
| CA2791445A1 (en) | 2011-07-21 |
| RU2557246C2 (ru) | 2015-07-20 |
| AU2011206611B2 (en) | 2015-03-05 |
| IL220707A0 (en) | 2012-08-30 |
| AU2011206611A1 (en) | 2012-08-02 |
| TWI485153B (zh) | 2015-05-21 |
| MX2012007835A (es) | 2012-07-30 |
| BR112012017393A2 (pt) | 2017-12-12 |
| EP2523961A1 (de) | 2012-11-21 |
| KR101759126B1 (ko) | 2017-07-18 |
| DK2523961T3 (en) | 2014-03-24 |
| EP2523961B1 (de) | 2013-12-18 |
| WO2011086075A1 (de) | 2011-07-21 |
| JP5844276B2 (ja) | 2016-01-13 |
| CN102791716B (zh) | 2016-05-11 |
| UY33176A (es) | 2011-08-31 |
| AR079980A1 (es) | 2012-03-07 |
| IL220707A (en) | 2015-02-26 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190107 |